Type I interferons (alpha/beta) in immunity and autoimmunity (Q36072422)

12 August 2017

1 reference

title

Type I interferons (alpha/beta) in immunity and autoimmunity (English)

1 reference

12 August 2017

3

Bruce Beutler

1 reference

12 August 2017

Argyrios N Theofilopoulos

series ordinal

1

1 reference

12 August 2017

Roberto Baccala

series ordinal

2

1 reference

12 August 2017

Dwight H Kono

series ordinal

4

1 reference

12 August 2017

language of work or name

1 reference

1 January 2005

1 reference

Annual Review of Immunology

12 August 2017

1 reference

12 August 2017

23

1 reference

12 August 2017

307-336

1 reference

Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential

12 August 2017

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Toll-like receptor control of the adaptive immune responses

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Immunology. After the toll rush.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Low dose poly I:C prevents diabetes in the diabetes prone BB rat

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Type I interferons keep activated T cells alive

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Activation of autoreactive B cells by CpG dsDNA

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Ingested type I interferon: a potential treatment for autoimmunity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Links between innate and adaptive immunity via type I interferon

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Amplification of IFN-alpha-induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Interferon-beta for treatment of rheumatoid arthritis?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Down-modulation of responses to type I IFN upon T cell activation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Requirement for IRF-1 in the microenvironment supporting development of natural killer cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Full house: 12 receptors for 27 cytokines

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

How we detect microbes and respond to them: the Toll-like receptors and their transducers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Immune Interferon in the Circulation of Patients with Autoimmune Disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Type I IFN protects against murine lupus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Autoimmunity through cytokine-induced dendritic cell activation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Type I interferon production enhances susceptibility to Listeria monocytogenes infection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

IFN-alpha priming results in a gain of proinflammatory function by IL-10: implications for systemic lupus erythematosus pathogenesis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Induction of murine autoimmune disease by chronic polyclonal B cell activation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Genetic differentiation of poly I:C from B:9-23 peptide induced experimental autoimmune diabetes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Homeostatic expansion of T cells during immune insufficiency generates autoimmunity.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

IFN-alpha/beta enhances BCR-dependent B cell responses

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Tumour necrosis factor and other cytokines in murine lupus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Induction of type I diabetes by interferon-alpha in transgenic mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Type I interferons produced by dendritic cells promote their phenotypic and functional activation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Constitutive IFN-alpha/beta signal for efficient IFN-alpha/beta gene induction by virus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Mouse and human dendritic cell subtypes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Islet expression of interferon-alpha precedes diabetes in both the BB rat and streptozotocin-treated mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Distinct requirements for IFNs and STAT1 in NK cell function

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Effect of interferons and poly(I):poly(C) on the pathogenesis of the diabetogenic variant of encephalomyocarditis virus in different mouse strains

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

The role of interleukin-10 in systemic lupus erythematosus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

The effects of interferon beta treatment on arthritis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Expression of a novel murine type I IFN in the pancreatic islets induces diabetes in mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

T cell homeostasis and systemic autoimmunity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Type I interferon modulation of cellular responses to cytokines and infectious pathogens: potential role in SLE pathogenesis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Viral infection switches non-plasmacytoid dendritic cells into high interferon producers.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Impairment of T and B cell development by treatment with a type I interferon

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Induction of clinical autoimmune disease by therapeutic interferon-alpha

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Rheumatoid arthritis induced by alpha-interferon therapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Interleukin-6 induces expression of Ifi202, an interferon-inducible candidate gene for lupus susceptibility

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Physiological β Cell Death Triggers Priming of Self-reactive T Cells by Dendritic Cells in a Type-1 Diabetes Model

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Evidence from Transgenic Mice That Interferon-β May Be Involved in the Onset of Diabetes Mellitus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Alpha-interferon inhibits the development of diabetes in NOD mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Viruses and diabetes.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Cross talk of the interferon-alpha/beta signalling complex with gp130 for effective interleukin-6 signalling

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Alpha interferon administration paradoxically inhibits the development of diabetes in BB rats

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Microarray studies of gene expression in circulating leukocytes in kidney diseases

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Cytokine signaling in 2002: new surprises in the Jak/Stat pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

A therapeutic role for BLyS antagonists

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Characterization of a common precursor population for dendritic cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

IL-28, IL-29 and their class II cytokine receptor IL-28R

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Interferons alpha and beta as immune regulators--a new look

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

The interferon system and interferon regulatory factor transcription factors -- studies from gene knockout mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Interleukin-10 and related cytokines and receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Identification of Lps2 as a key transducer of MyD88-independent TIR signalling

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Onset of insulin-dependent diabetes mellitus after interferon-alfa therapy for hairy cell leukaemia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

How cells respond to interferons

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Interferon-producing cells: on the front line in immune responses against pathogens

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

An etiopathogenic role for the type I IFN system in SLE.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Multistage regulation of Th1-type immune responses by the transcription factor IRF-1

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Interferon alpha--a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

A weak signal for strong responses: interferon-alpha/beta revisited

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Requirement of the IFN-alpha/beta-induced CXCR3 chemokine signalling for CD8+ T cell activation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Immunostimulation circumvents diabetes in NOD/Lt mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

IRF family of transcription factors as regulators of host defense

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB x NZWF1 mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Regulation of JAK-STAT signalling in the immune system

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

New Omomyid Primates (Haplorhini, Tarsiiformes) from Middle Eocene Rocks of West-Central Hot Springs County, Wyoming

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Cell-type and donor-specific transcriptional responses to interferon-alpha. Use of customized gene arrays.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Suppressor of Cytokine Signaling-1 Is Essential for Suppressing Dendritic Cell Activation and Systemic Autoimmunity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

The human interferon alpha species and receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Oral use of interferon-alpha delays the onset of insulin-dependent diabetes mellitus in nonobese diabetes mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Interferon-alpha: a new target for therapy in systemic lupus erythematosus?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.23.021704.115843

Identifiers

DOI

10.1146/ANNUREV.IMMUNOL.23.021704.115843

1 reference

12 August 2017

1 reference